Pharmamarketeer

EMA’s PRIME enables earlier availability of life─changing medicines

Life─changing medicines

EMA’s PRIority Medicines (PRIME) scheme has had a positive impact on the authorisation of new medicines that address patients’ unmet medical needs. The time to marketing authorisation was reduced for medicines that

Advertentie(s)